TCS inks deal with Swiss health group

Tata Consultancy Services, a leading IT services, business solutions and outsourcing firm has inked a partnership with the Swiss researched-focused health group Roche, and will basically support the demands of Roche’s increasing drug pipeline and advance Roche’s global capacity building initiative (GCBI).
This new initiative will provide services to a number of areas in Roche’s development organisation, including clinical data management, clinical programming, biostatistics and drug safety support. The aim of the collaboration between TCS and Roche is to create a flexible, scalable and high-quality partnership to support the demands of Roche’s increasing drug pipeline.
Mr Jean-Jacques Garaud, global head of pharma development at Roche, commented: "For Roche, it was key to find the best partner for our GCBI initiative and the collaboration with TCS is the result of an extensive international search. It will allow us to address the growing operational needs of our development organisation and to handle the increasing workload."
The Life Sciences and Healthcare Practice at TCS has over 3,200 professional including pharmacologists, physicians, biomedical engineers, biostatisticians, ICH/GCP compliance professionals, GxP consultants, PhDs, IT architects, consultants and management graduates who were focused on providing best in class IT consulting, solutions and services to Life Sciences and Healthcare customers.
Mr J. Rajagopal, TCS executive vice-president and global head, life sciences and healthcare, said: "The global capacity building initiative with Roche is another validation of TCS’ strategy to focus on services supporting the drug development processes and the investments made in building our domain competencies in this area."